{"id":"W7097935691","doi":"","title":"pancreatic cancer","year":2016,"lang":"en","type":"article","venue":"","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Erlotinib; Gemcitabine; Pancreatic cancer; Clinical trial; Chemotherapy; Epidermal growth factor receptor; EGFR inhibitors; Erlotinib Hydrochloride","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004605572,0.0007224814,0.0006566335,0.0012279,0.0009892111,0.002576936,0.0005428644,0.001123925,0.07077828],"category_scores_gemma":[0.0008644093,0.0002010298,0.0008139008,0.001900689,0.0003374319,0.0009688654,0.001319564,0.00180987,0.04980665],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001206653,"about_ca_system_score_gemma":0.001335283,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001612473,"about_ca_topic_score_gemma":0.001865397,"domain_scores_codex":[0.9996581,0.00003493239,0.00003695981,0.0000818212,0.0001087799,0.00007939077],"domain_scores_gemma":[0.9996821,0.00002428694,0.00003681912,0.00005279486,0.0001147544,0.00008928793],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0007507485,0.0001694187,0.007647057,0.001933478,0.000125544,0.0101408,0.0001550424,0.000200678,0.006705223,0.006530614,0.2754011,0.6902403],"study_design_scores_gemma":[0.00008497034,0.0001097142,0.004626495,0.0003674533,0.00007408744,0.02407033,0.0001182894,0.00008855207,0.0033896,0.002040611,0.9650154,0.00001454367],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"other","genre_gemma":"other","genre_scores_codex":[0.03651782,0.1433686,0.009483192,0.0224175,0.009098005,0.0006907645,0.01446084,0.002444588,0.7615187],"genre_scores_gemma":[0.2325358,0.1023106,0.01231318,0.01784018,0.004572852,0.0004886098,0.0349667,0.0006848587,0.5942872],"genre_candidate":"other","genre_consensus":"other","teacher_disagreement_score":0.07077828,"threshold_uncertainty_score":0.2367769,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04791394731014693,"score_gpt":0.3870708875062753,"score_spread":0.3391569401961284,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}